Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC in Biliary Atresia After Kasai Portoenterostomy
NCT03499249Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- May 2018
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in biliary atresia, sponsored by Baylor College of Medicine. Started May 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
biliary atresia
Beyond the preview
Go deeper on NCT03499249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03499249.